If your drug company is on its death-bed, this is the man you want as your corporate doctor. He's Fred Hassan, the CEO of drug giant Schering-Plough. In the past 25 years, he has turned around his fair share of ailing pharmaceutical firms, including the recovery and subsequent 56 billion dollar sale of Pharmacia. He's so renowned within his industry that they coined a phrase for his brand of management: "The Fred Factor." Hassan tells The Boardroom's Maggie Lake how he is able to assess, diagnose and cure.
As Schering-Plough unveils full-year financial results for 2007 tomorrow, CEO Fred Hassan is likely to be peppered with questions about how he managed a recently released study of embattled cholesterol drug, Vytorin.